Who backs Vivace Therapeutics?
11 investors| Investor | Type |
|---|---|
| Sequoia Capital | Venture capital |
| Hongshan Capital Group | Other |
| RA Capital Management | Asset manager |
| Canaan Partners | Venture capital |
| Mission BioCapital | Venture capital |
| WuXi Healthcare Ventures | Other |
| 120 Capital | — |
| 6 Dimensions Capital | — |
| Boxer Capital | — |
| Cenova Capital | — |
| + 1 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Vivace Therapeutics investors
11 investors are on record for Vivace Therapeutics, including Sequoia Capital, Hongshan Capital Group, RA Capital Management and Canaan Partners. The Series D in Feb 2025 drew 2 investors.
Free account
More of Vivace Therapeutics with a free account
- ·The complete investor list: 11 names
- ·Watch Vivace Therapeutics: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 11 firms already write checks for companies like Vivace Therapeutics in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View